{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T20:01:25Z","timestamp":1784577685886,"version":"3.55.0"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T00:00:00Z","timestamp":1784332800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"vor","delay-in-days":2,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflamm Regener"],"DOI":"10.1186\/s41232-026-00432-6","type":"journal-article","created":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T01:32:58Z","timestamp":1784338378000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Autoreactive B cells in systemic lupus erythematosus: insights from integrative multi-omics analyses"],"prefix":"10.1186","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5678-8138","authenticated-orcid":false,"given":"Toshiyuki Shiki","family":"Ushijima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohisa","family":"Okamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keishi","family":"Fujio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,18]]},"reference":[{"key":"432_CR1","doi-asserted-by":"publisher","first-page":"16039","DOI":"10.1038\/nrdp.2016.39","volume":"2","author":"A Kaul","year":"2016","unstructured":"Kaul A, Gordon C, Crow MK, Touma Z, Urowitz MB, van Vollenhoven R, et al. Systemic lupus erythematosus. Nat Rev Dis Primers. 2016;2:16039. https:\/\/doi.org\/10.1038\/nrdp.2016.39.","journal-title":"Nat Rev Dis Primers"},{"issue":"9","key":"432_CR2","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/s41584-021-00668-1","volume":"17","author":"MRW Barber","year":"2021","unstructured":"Barber MRW, Drenkard C, Falasinnu T, Hoi A, Mak A, Kow NY, et al. Global epidemiology of systemic lupus erythematosus. Nat Rev Rheumatol. 2021;17(9):515\u201332. https:\/\/doi.org\/10.1038\/s41584-021-00668-1.","journal-title":"Nat Rev Rheumatol"},{"key":"432_CR3","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ejim.2023.02.004","volume":"112","author":"M Zen","year":"2023","unstructured":"Zen M, Salmaso L, BarbielliniAmidei C, Fedeli U, Bellio S, Iaccarino L, et al. Mortality and causes of death in systemic lupus erythematosus over the last decade: Data from a large population-based study. Eur J Intern Med. 2023;112:45\u201351. https:\/\/doi.org\/10.1016\/j.ejim.2023.02.004.","journal-title":"Eur J Intern Med"},{"issue":"1","key":"432_CR4","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1136\/ard-2024-226430","volume":"84","author":"F Del Galdo","year":"2025","unstructured":"Del Galdo F, Lescoat A, Conaghan PG, Bertoldo E, Colic J, Santiago T, et al. Eular recommendations for the treatment of systemic sclerosis: 2023 update. Ann Rheum Dis. 2025;84(1):29\u201340. https:\/\/doi.org\/10.1136\/ard-2024-226430.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"432_CR5","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/s41584-023-00948-y","volume":"19","author":"S Fasano","year":"2023","unstructured":"Fasano S, Milone A, Nicoletti GF, Isenberg DA, Ciccia F. Precision medicine in systemic lupus erythematosus. Nat Rev Rheumatol. 2023;19(6):331\u201342. https:\/\/doi.org\/10.1038\/s41584-023-00948-y.","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"432_CR6","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/s43586-021-00056-9","volume":"1","author":"E Uffelmann","year":"2021","unstructured":"Uffelmann E, Huang QQ, Munung NS, de Vries J, Okada Y, Martin AR, et al. Genome-wide association studies. Nature Reviews Methods Primers. 2021;1(1):59. https:\/\/doi.org\/10.1038\/s43586-021-00056-9.","journal-title":"Nature Reviews Methods Primers"},{"issue":"9","key":"432_CR7","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1038\/s41588-021-00913-z","volume":"53","author":"U Vosa","year":"2021","unstructured":"Vosa U, Claringbould A, Westra HJ, Bonder MJ, Deelen P, Zeng B, et al. Large-scale cis- and trans-eqtl analyses identify thousands of genetic loci and polygenic scores that regulate blood gene expression. Nat Genet. 2021;53(9):1300\u201310.","journal-title":"Nat Genet"},{"issue":"11","key":"432_CR8","doi-asserted-by":"publisher","first-page":"3006","DOI":"10.1016\/j.cell.2021.03.056","volume":"184","author":"M Ota","year":"2021","unstructured":"Ota M, Nagafuchi Y, Hatano H, Ishigaki K, Terao C, Takeshima Y, et al. Dynamic landscape of immune cell-specific gene regulation in immune-mediated diseases. Cell. 2021;184(11):3006-3021 e3017.","journal-title":"Cell"},{"issue":"1","key":"432_CR9","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/s41368-021-00146-0","volume":"13","author":"X Li","year":"2021","unstructured":"Li X, Wang CY. From bulk, single-cell to spatial rna sequencing. Int J Oral Sci. 2021;13(1):36. https:\/\/doi.org\/10.1038\/s41368-021-00146-0.","journal-title":"Int J Oral Sci"},{"issue":"775","key":"432_CR10","doi-asserted-by":"publisher","first-page":"eadl1666","DOI":"10.1126\/scitranslmed.adl1666","volume":"16","author":"P Danaher","year":"2024","unstructured":"Danaher P, Hasle N, Nguyen ED, Roberts JE, Rosenwasser N, Rickert C, et al. Childhood-onset lupus nephritis is characterized by complex interactions between kidney stroma and infiltrating immune cells. Sci Transl Med. 2024;16(775):eadl1666.","journal-title":"Sci Transl Med"},{"issue":"6589","key":"432_CR11","doi-asserted-by":"publisher","first-page":"eabf1970","DOI":"10.1126\/science.abf1970","volume":"376","author":"RK Perez","year":"2022","unstructured":"Perez RK, Gordon MG, Subramaniam M, Kim MC, Hartoularos GC, Targ S, et al. Single-cell rna-seq reveals cell type-specific molecular and genetic associations to lupus. Science. 2022;376(6589):eabf1970. https:\/\/doi.org\/10.1126\/science.abf1970.","journal-title":"Science"},{"issue":"11","key":"432_CR12","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1038\/s41590-025-02291-8","volume":"26","author":"Z Sultana","year":"2025","unstructured":"Sultana Z, Khatri R, Yousefi B, Shaikh N, Jauch-Speer SL, Schaub DP, et al. Spatiotemporal interaction of immune and renal cells controls glomerular crescent formation in autoimmune kidney disease. Nat Immunol. 2025;26(11):1977\u201388. https:\/\/doi.org\/10.1038\/s41590-025-02291-8.","journal-title":"Nat Immunol"},{"issue":"12","key":"432_CR13","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1016\/j.ard.2025.08.015","volume":"84","author":"J Wang","year":"2025","unstructured":"Wang J, Zheng A, Liu N, Tan Z, Shi Y, Ma T, et al. Integrative spatial multiomics analysis reveals regulatory mechanisms of VCAM1(+) proximal tubule cells in lupus nephritis. Ann Rheum Dis. 2025;84(12):2021\u201333. https:\/\/doi.org\/10.1016\/j.ard.2025.08.015.","journal-title":"Ann Rheum Dis"},{"key":"432_CR14","doi-asserted-by":"publisher","unstructured":"Wu C, Jiang S, Chen Z, Li T, Gu X, Dai M, et al. Single-cell transcriptomics reveal potent extrafollicular b cell response linked with granzyme k(+) cd8 t cell activation in lupus kidney. Ann Rheum Dis. 2024. https:\/\/doi.org\/10.1136\/ard-2024-225876.","DOI":"10.1136\/ard-2024-225876"},{"issue":"824","key":"432_CR15","doi-asserted-by":"publisher","first-page":"eady0210","DOI":"10.1126\/scitranslmed.ady0210","volume":"17","author":"S Younis","year":"2025","unstructured":"Younis S, Moutusy SI, Rasouli S, Jahanbani S, Pandit M, Wu X, et al. Epstein-Barr virus reprograms autoreactive B cells as antigen-presenting cells in systemic lupus erythematosus. Sci Transl Med. 2025;17(824):eady0210. https:\/\/doi.org\/10.1126\/scitranslmed.ady0210.","journal-title":"Sci Transl Med"},{"issue":"4","key":"432_CR16","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1002\/art.42750","volume":"76","author":"C Dong","year":"2024","unstructured":"Dong C, Guo Y, Chen Z, Li T, Ji J, Sun C, et al. Single-cell profiling of bone marrow b cells and early b cell developmental disorders associated with systemic lupus erythematosus. Arthritis Rheumatol. 2024;76(4):599\u2013613. https:\/\/doi.org\/10.1002\/art.42750.","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"432_CR17","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/imr.12741","volume":"288","author":"SA Jenks","year":"2019","unstructured":"Jenks SA, Cashman KS, Woodruff MC, Lee FE, Sanz I. Extrafollicular responses in humans and sle. Immunol Rev. 2019;288(1):136\u201348. https:\/\/doi.org\/10.1111\/imr.12741.","journal-title":"Immunol Rev"},{"issue":"5","key":"432_CR18","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/nri.2017.19","volume":"17","author":"D Nemazee","year":"2017","unstructured":"Nemazee D. Mechanisms of central tolerance for b cells. Nat Rev Immunol. 2017;17(5):281\u201394. https:\/\/doi.org\/10.1038\/nri.2017.19.","journal-title":"Nat Rev Immunol"},{"issue":"12","key":"432_CR19","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1038\/nrrheum.2010.176","volume":"6","author":"Y Deng","year":"2010","unstructured":"Deng Y, Tsao BP. Genetic susceptibility to systemic lupus erythematosus in the genomic era. Nat Rev Rheumatol. 2010;6(12):683\u201392. https:\/\/doi.org\/10.1038\/nrrheum.2010.176.","journal-title":"Nat Rev Rheumatol"},{"issue":"11","key":"432_CR20","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1038\/ng.3404","volume":"47","author":"HK Finucane","year":"2015","unstructured":"Finucane HK, Bulik-Sullivan B, Gusev A, Trynka G, Reshef Y, Loh PR, et al. Partitioning heritability by functional annotation using genome-wide association summary statistics. Nat Genet. 2015;47(11):1228\u201335. https:\/\/doi.org\/10.1038\/ng.3404.","journal-title":"Nat Genet"},{"issue":"2","key":"432_CR21","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1002\/rai2.70001","volume":"5","author":"K Fujio","year":"2025","unstructured":"Fujio K, Ushijima T, Abe T, Okamura T, Bae SC, Tsuchida Y. Treatment strategy for systemic lupus erythematosus using belimumab as indicated by multi-omics analysis. Rheumatol Autoimmunity. 2025;5(2):81\u20137. https:\/\/doi.org\/10.1002\/rai2.70001.","journal-title":"Rheumatol Autoimmunity"},{"key":"432_CR22","doi-asserted-by":"publisher","first-page":"2458","DOI":"10.3389\/fimmu.2019.02458","volume":"10","author":"I Sanz","year":"2019","unstructured":"Sanz I, Wei C, Jenks SA, Cashman KS, Tipton C, Woodruff MC, et al. Challenges and opportunities for consistent classification of human b cell and plasma cell populations. Front Immunol. 2019;10:2458. https:\/\/doi.org\/10.3389\/fimmu.2019.02458.","journal-title":"Front Immunol"},{"issue":"7639","key":"432_CR23","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/nature20810","volume":"542","author":"DA Rao","year":"2017","unstructured":"Rao DA, Gurish MF, Marshall JL, Slowikowski K, Fonseka CY, Liu Y, et al. Pathologically expanded peripheral t helper cell subset drives b cells in rheumatoid arthritis. Nature. 2017;542(7639):110\u20134. https:\/\/doi.org\/10.1038\/nature20810.","journal-title":"Nature"},{"key":"432_CR24","doi-asserted-by":"publisher","unstructured":"Goto M, Takahashi H, Yoshida R, Itamiya T, Nakano M, Nagafuchi Y, et al. Age-associated cd4+ t cells with b cell-promoting functions are regulated by zeb2 in autoimmunity. Sci Immunol. 2024;9(93):eadk1643. https:\/\/doi.org\/10.1126\/sciimmunol.adk1643.","DOI":"10.1126\/sciimmunol.adk1643"},{"issue":"6681","key":"432_CR25","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1126\/science.adf8531","volume":"383","author":"D Dai","year":"2024","unstructured":"Dai D, Gu S, Han X, Ding H, Jiang Y, Zhang X, et al. The transcription factor zeb2 drives the formation of age-associated b cells. Science. 2024;383(6681):413\u201321. https:\/\/doi.org\/10.1126\/science.adf8531.","journal-title":"Science"},{"key":"432_CR26","doi-asserted-by":"publisher","unstructured":"Levack RC, Newell KL, Popescu M, Cabrera-Martinez B, Winslow GM. Cd11c(+) t-bet(+) b cells require il-21 and ifn-gamma from type 1 t follicular helper cells and intrinsic bcl-6 expression but develop normally in the absence of t-bet. J Immunol. 2020;205(4):1050\u20131058.https:\/\/doi.org\/10.4049\/jimmunol.2000206.","DOI":"10.4049\/jimmunol.2000206"},{"key":"432_CR27","doi-asserted-by":"publisher","unstructured":"Bocharnikov AV, Keegan J, Wacleche VS, Cao Y, Fonseka CY, Wang G, et al. Pd-1hicxcr5- t peripheral helper cells promote b cell responses in lupus via maf and il-21. JCI Insight. 2019;4(20). https:\/\/doi.org\/10.1172\/jci.insight.130062.","DOI":"10.1172\/jci.insight.130062"},{"issue":"7909","key":"432_CR28","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41586-022-04642-z","volume":"605","author":"GJ Brown","year":"2022","unstructured":"Brown GJ, Canete PF, Wang H, Medhavy A, Bones J, Roco JA, et al. Tlr7 gain-of-function genetic variation causes human lupus. Nature. 2022;605(7909):349\u201356. https:\/\/doi.org\/10.1038\/s41586-022-04642-z.","journal-title":"Nature"},{"issue":"5","key":"432_CR29","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1182\/blood-2011-01-331462","volume":"118","author":"AV Rubtsov","year":"2011","unstructured":"Rubtsov AV, Rubtsova K, Fischer A, Meehan RT, Gillis JZ, Kappler JW, et al. Toll-like receptor 7 (TLR7)-driven accumulation of a novel CD11c(+) B-cell population is important for the development of autoimmunity. Blood. 2011;118(5):1305\u201315. https:\/\/doi.org\/10.1182\/blood-2011-01-331462.","journal-title":"Blood"},{"issue":"4","key":"432_CR30","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.immuni.2018.08.015","volume":"49","author":"SA Jenks","year":"2018","unstructured":"Jenks SA, Cashman KS, Zumaquero E, Marigorta UM, Patel AV, Wang X, et al. Distinct effector b cells induced by unregulated toll-like receptor 7 contribute to pathogenic responses in systemic lupus erythematosus. Immunity. 2018;49(4):725-739 e726. https:\/\/doi.org\/10.1016\/j.immuni.2018.08.015.","journal-title":"Immunity"},{"issue":"1","key":"432_CR31","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1038\/s41467-018-03750-7","volume":"9","author":"S Wang","year":"2018","unstructured":"Wang S, Wang J, Kumar V, Karnell JL, Naiman B, Gross PS, et al. IL-21 drives expansion and plasma cell differentiation of autoreactive CD11c(hi)T-bet(+) B cells in SLE. Nat Commun. 2018;9(1):1758.","journal-title":"Nat Commun"},{"key":"432_CR32","doi-asserted-by":"publisher","unstructured":"Al-Aubodah TA, Aoudjit L, Pascale G, Perinpanayagam MA, Langlais D, Bitzan M, et al. The extrafollicular b cell response is a hallmark of childhood idiopathic nephrotic syndrome. Nat Commun. 2023;14(1):7682.\u00a0https:\/\/doi.org\/10.1038\/s41467-023-43504-8.","DOI":"10.1038\/s41467-023-43504-8"},{"issue":"1","key":"432_CR33","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41590-024-02010-9","volume":"26","author":"CE Faliti","year":"2025","unstructured":"Faliti CE, Van TTP, Anam FA, Cheedarla N, Williams ME, Mishra AK, et al. Disease-associated B cells and immune endotypes shape adaptive immune responses to SARS-CoV-2 mRNA vaccination in human SLE. Nat Immunol. 2025;26(1):131\u201345.","journal-title":"Nat Immunol"},{"key":"432_CR34","doi-asserted-by":"publisher","unstructured":"Holla P, Dizon B, Ambegaonkar A, Rogel N, Goldschmidt E, Boddapati A, et al. Shared transcriptional profiles of atypical b cells suggest common drivers of expansion and function in malaria, hiv, and autoimmunity. Sci Adv. 2021;7(22):eabg8384. https:\/\/doi.org\/10.1126\/sciadv.abg8384.","DOI":"10.1126\/sciadv.abg8384"},{"issue":"5","key":"432_CR35","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1016\/j.cell.2021.01.050","volume":"184","author":"A Sokal","year":"2021","unstructured":"Sokal A, Chappert P, Barba-Spaeth G, Roeser A, Fourati S, Azzaoui I, et al. Maturation and persistence of the anti-SARS-CoV-2 memory B cell response. Cell. 2021;184(5):1201-1213 e1214.","journal-title":"Cell"},{"key":"432_CR36","doi-asserted-by":"publisher","unstructured":"Yam-Puc JC, Hosseini Z, Horner EC, Gerber PP, Beristain-Covarrubias N, Hughes R, et al. Age-associated b cells predict impaired humoral immunity after covid-19 vaccination in patients receiving immune checkpoint blockade. Nat Commun. 2023;14(1):3292 https:\/\/doi.org\/10.1038\/s41467-023-38810-0.","DOI":"10.1038\/s41467-023-38810-0"},{"key":"432_CR37","doi-asserted-by":"publisher","unstructured":"Wang C, Evangelista JF, Vidal AKN, Islamuddin M, Chen Y, Xu D, et al. The emerging role of tlr7-mediated signaling in respiratory viral infections and autoimmune diseases. Cell Mol Life Sci. 2026;83(1). https:\/\/doi.org\/10.1007\/s00018-026-06144-x.","DOI":"10.1007\/s00018-026-06144-x"},{"issue":"8","key":"432_CR38","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1038\/s41590-019-0419-9","volume":"20","author":"CD Scharer","year":"2019","unstructured":"Scharer CD, Blalock EL, Mi T, Barwick BG, Jenks SA, Deguchi T, et al. Epigenetic programming underpins b cell dysfunction in human SLE. Nat Immunol. 2019;20(8):1071\u201382. https:\/\/doi.org\/10.1038\/s41590-019-0419-9.","journal-title":"Nat Immunol"},{"issue":"1","key":"432_CR39","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s10238-018-0535-0","volume":"19","author":"ZX Li","year":"2019","unstructured":"Li ZX, Zeng S, Wu HX, Zhou Y. The risk of systemic lupus erythematosus associated with epstein-barr virus infection: A systematic review and meta-analysis. Clin Exp Med. 2019;19(1):23\u201336. https:\/\/doi.org\/10.1007\/s10238-018-0535-0.","journal-title":"Clin Exp Med"},{"issue":"1","key":"432_CR40","doi-asserted-by":"publisher","first-page":"9998","DOI":"10.1038\/s41598-019-46329-y","volume":"9","author":"JYJ Neo","year":"2019","unstructured":"Neo JYJ, Wee SYK, Bonne I, Tay SH, Raida M, Jovanovic V, et al. Characterisation of a human antibody that potentially links cytomegalovirus infection with systemic lupus erythematosus. Sci Rep. 2019;9(1):9998. https:\/\/doi.org\/10.1038\/s41598-019-46329-y.","journal-title":"Sci Rep"},{"key":"432_CR41","doi-asserted-by":"publisher","unstructured":"Younis S, Moutusy S, Rasouli S, Jahanbani S, Pandit M, Wu X, et al. Epstein-barr virus reprograms autoreactive b cells as antigen-presenting cells in systemic lupus erythematosus. Sci Transl Med. 2025;17(824):eady0210. https:\/\/doi.org\/10.1126\/scitranslmed.ady0210.","DOI":"10.1126\/scitranslmed.ady0210"},{"issue":"21","key":"432_CR42","doi-asserted-by":"publisher","first-page":"6071","DOI":"10.1016\/j.cell.2024.08.025","volume":"187","author":"S Mori","year":"2024","unstructured":"Mori S, Kohyama M, Yasumizu Y, Tada A, Tanzawa K, Shishido T, et al. Neoself-antigens are the primary target for autoreactive t cells in human lupus. Cell. 2024;187(21):6071-6087 e6020. https:\/\/doi.org\/10.1016\/j.cell.2024.08.025.","journal-title":"Cell"},{"issue":"9","key":"432_CR43","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1038\/nmeth.4380","volume":"14","author":"M Stoeckius","year":"2017","unstructured":"Stoeckius M, Hafemeister C, Stephenson W, Houck-Loomis B, Chattopadhyay PK, Swerdlow H, et al. Simultaneous epitope and transcriptome measurement in single cells. Nat Methods. 2017;14(9):865\u20138. https:\/\/doi.org\/10.1038\/nmeth.4380.","journal-title":"Nat Methods"},{"issue":"3","key":"432_CR44","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.cell.2016.03.008","volume":"165","author":"R Banchereau","year":"2016","unstructured":"Banchereau R, Hong S, Cantarel B, Baldwin N, Baisch J, Edens M, et al. Personalized immunomonitoring uncovers molecular networks that stratify lupus patients. Cell. 2016;165(3):551\u201365. https:\/\/doi.org\/10.1016\/j.cell.2016.03.008.","journal-title":"Cell"},{"issue":"4","key":"432_CR45","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1038\/s41591-020-0769-8","volume":"26","author":"Y Kotliarov","year":"2020","unstructured":"Kotliarov Y, Sparks R, Martins AJ, Mule MP, Lu Y, Goswami M, et al. Broad immune activation underlies shared set point signatures for vaccine responsiveness in healthy individuals and disease activity in patients with lupus. Nat Med. 2020;26(4):618\u201329. https:\/\/doi.org\/10.1038\/s41591-020-0769-8.","journal-title":"Nat Med"},{"issue":"4","key":"432_CR46","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1038\/s41592-025-02617-2","volume":"22","author":"S Marco Salas","year":"2025","unstructured":"Marco Salas S, Kuemmerle LB, Mattsson-Langseth C, Tismeyer S, Avenel C, Hu T, et al. Optimizing xenium in situ data utility by quality assessment and best-practice analysis workflows. Nat Methods. 2025;22(4):813\u201323. https:\/\/doi.org\/10.1038\/s41592-025-02617-2.","journal-title":"Nat Methods"},{"key":"432_CR47","doi-asserted-by":"publisher","unstructured":"van Dam S, Baars MJD, Vercoulen Y. Multiplex tissue imaging: Spatial revelations in the tumor microenvironment. Cancers (Basel). 2022;14(13). https:\/\/doi.org\/10.3390\/cancers14133170.","DOI":"10.3390\/cancers14133170"},{"key":"432_CR48","doi-asserted-by":"publisher","unstructured":"Montorsi L, Pitcher MJ, Zhao Y, Dionisi C, Demonti A, Tull TJ, et al. Double-negative b cells and dnase1l3 colocalise with microbiota in gut-associated lymphoid tissue. Nat Commun. 2024;15(1):4051.\u00a0https:\/\/doi.org\/10.1038\/s41467-024-48267-4.","DOI":"10.1038\/s41467-024-48267-4"},{"key":"432_CR49","doi-asserted-by":"publisher","unstructured":"Hartl J, Serpas L, Wang Y, Rashidfarrokhi A, Perez OA, Sally B, et al. Autoantibody-mediated impairment of dnase1l3 activity in sporadic systemic lupus erythematosus. J Exp Med. 2021;218(5). https:\/\/doi.org\/10.1084\/jem.20201138.","DOI":"10.1084\/jem.20201138"},{"key":"432_CR50","doi-asserted-by":"publisher","unstructured":"Soni C, Perez OA, Voss WN, Pucella JN, Serpas L, Mehl J, et al. Plasmacytoid dendritic cells and type i interferon promote extrafollicular b cell responses to extracellular self-DNA. Immunity. 2020;52(6):1022\u20131038 e1027.\u00a0https:\/\/doi.org\/10.1016\/j.immuni.2020.04.015.","DOI":"10.1016\/j.immuni.2020.04.015"},{"issue":"7993","key":"432_CR51","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41586-023-06837-4","volume":"625","author":"AJC Russell","year":"2024","unstructured":"Russell AJC, Weir JA, Nadaf NM, Shabet M, Kumar V, Kambhampati S, et al. Slide-tags enables single-nucleus barcoding for multimodal spatial genomics. Nature. 2024;625(7993):101\u20139.","journal-title":"Nature"},{"key":"432_CR52","doi-asserted-by":"publisher","unstructured":"Huynh KLA, Tyc KM, Matuck BF, Easter QT, Pratapa A, Kumar NV, et al. Deconvolution of cell types and states in spatial multiomics utilizing tacit. Nat Commun. 2025;16(1):3747.\u00a0https:\/\/doi.org\/10.1038\/s41467-025-58874-4.","DOI":"10.1038\/s41467-025-58874-4"},{"issue":"5909","key":"432_CR53","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/302575a0","volume":"302","author":"S Tonegawa","year":"1983","unstructured":"Tonegawa S. Somatic generation of antibody diversity. Nature. 1983;302(5909):575\u201381.","journal-title":"Nature"},{"key":"432_CR54","doi-asserted-by":"publisher","unstructured":"Morgan DM, Zhang YJ, Kim JH, Murillo M, Singh S, Loschko J, et al. Full-length single-cell bcr sequencing paired with rna sequencing reveals convergent responses to pneumococcal vaccination. Commun Biol. 2024;7(1):1208.\u00a0https:\/\/doi.org\/10.1038\/s42003-024-06823-0.","DOI":"10.1038\/s42003-024-06823-0"},{"issue":"7","key":"432_CR55","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1038\/ni.3175","volume":"16","author":"CM Tipton","year":"2015","unstructured":"Tipton CM, Fucile CF, Darce J, Chida A, Ichikawa T, Gregoretti I, et al. Diversity, cellular origin and autoreactivity of antibody-secreting cell population expansions in acute systemic lupus erythematosus. Nat Immunol. 2015;16(7):755\u201365.","journal-title":"Nat Immunol"},{"issue":"10","key":"432_CR56","doi-asserted-by":"publisher","first-page":"4926","DOI":"10.4049\/jimmunol.1202263","volume":"191","author":"C Richardson","year":"2013","unstructured":"Richardson C, Chida AS, Adlowitz D, Silver L, Fox E, Jenks SA, et al. Molecular basis of 9g4 b cell autoreactivity in human systemic lupus erythematosus. J Immunol. 2013;191(10):4926\u201339. https:\/\/doi.org\/10.4049\/jimmunol.1202263.","journal-title":"J Immunol"},{"issue":"11","key":"432_CR57","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1136\/ard-2023-224421","volume":"82","author":"M Ota","year":"2023","unstructured":"Ota M, Nakano M, Nagafuchi Y, Kobayashi S, Hatano H, Yoshida R, et al. Multimodal repertoire analysis unveils b cell biology in immune-mediated diseases. Ann Rheum Dis. 2023;82(11):1455\u201363. https:\/\/doi.org\/10.1136\/ard-2023-224421.","journal-title":"Ann Rheum Dis"},{"key":"432_CR58","doi-asserted-by":"publisher","unstructured":"Ushijima T, Teruya H, Abe T, Itamiya T, Ota M, Okamura T, et al. Stratification of systemic lupus erythematosus with ighv4\u201334 in unswitched memory b cells. Rheumatology (Oxford). 2025:keaf386. https:\/\/doi.org\/10.1093\/rheumatology\/keaf386\u00a0.","DOI":"10.1093\/rheumatology\/keaf386"},{"issue":"3","key":"432_CR59","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/s41584-020-0374-8","volume":"16","author":"JCA Broen","year":"2020","unstructured":"Broen JCA, van Laar JM. Mycophenolate mofetil, azathioprine and tacrolimus: Mechanisms in rheumatology. Nat Rev Rheumatol. 2020;16(3):167\u201378. https:\/\/doi.org\/10.1038\/s41584-020-0374-8.","journal-title":"Nat Rev Rheumatol"},{"key":"432_CR60","doi-asserted-by":"publisher","unstructured":"Harigai M, Kawamoto M, Hara M, Kubota T, Kamatani N, Miyasaka N. Excessive production of ifn-gamma in patients with systemic lupus erythematosus and its contribution to induction of b lymphocyte stimulator\/b cell-activating factor\/tnf ligand superfamily-13b. J Immunol. 2008;181(3):2211-9. https:\/\/doi.org\/10.4049\/jimmunol.181.3.2211.","DOI":"10.4049\/jimmunol.181.3.2211"},{"key":"432_CR61","doi-asserted-by":"publisher","unstructured":"Zumaquero E, Stone SL, Scharer CD, Jenks SA, Nellore A, Mousseau B, et al. Ifngamma induces epigenetic programming of human t-bet(hi) b cells and promotes tlr7\/8 and il-21 induced differentiation. Elife 2019;8. https:\/\/doi.org\/10.7554\/eLife.41641.","DOI":"10.7554\/eLife.41641"},{"issue":"8","key":"432_CR62","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1038\/s41423-021-00713-9","volume":"18","author":"Q Fu","year":"2021","unstructured":"Fu Q, Zhang X. From blood to tissue: take a deeper look at b cells in lupus. Cell Mol Immunol. 2021;18(8):2073\u20134. https:\/\/doi.org\/10.1038\/s41423-021-00713-9.","journal-title":"Cell Mol Immunol"},{"key":"432_CR63","doi-asserted-by":"publisher","DOI":"10.1126\/science.1086907","author":"H Wardemann","year":"2003","unstructured":"Wardemann H, Yurasov S, Schaefer A, Young J, Meffre E, Nussenzweig M. Predominant autoantibody production by early human b cell precursors. Science. 2003. https:\/\/doi.org\/10.1126\/science.1086907.","journal-title":"Science"},{"issue":"6695","key":"432_CR64","doi-asserted-by":"publisher","DOI":"10.1126\/science.adj4857","volume":"384","author":"J Ma","year":"2024","unstructured":"Ma J, Wu Y, Ma L, Yang X, Zhang T, Song G, et al. A blueprint for tumor-infiltrating b cells across human cancers. Science. 2024;384(6695):eadj4857. https:\/\/doi.org\/10.1126\/science.adj4857.","journal-title":"Science"},{"issue":"2","key":"432_CR65","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/s41584-024-01210-9","volume":"21","author":"M Stockfelt","year":"2025","unstructured":"Stockfelt M, Teng YKO, Vital EM. Opportunities and limitations of b cell depletion approaches in sle. Nat Rev Rheumatol. 2025;21(2):111\u201326. https:\/\/doi.org\/10.1038\/s41584-024-01210-9.","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"432_CR66","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1136\/ard-2023-224762","volume":"83","author":"A Fanouriakis","year":"2024","unstructured":"Fanouriakis A, Kostopoulou M, Andersen J, Aringer M, Arnaud L, Bae SC, et al. Eular recommendations for the management of systemic lupus erythematosus: 2023 update. Ann Rheum Dis. 2024;83(1):15\u201329. https:\/\/doi.org\/10.1136\/ard-2023-224762.","journal-title":"Ann Rheum Dis"},{"issue":"7776","key":"432_CR67","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/s41586-019-1595-3","volume":"574","author":"RJM Bashford-Rogers","year":"2019","unstructured":"Bashford-Rogers RJM, Bergamaschi L, McKinney EF, Pombal DC, Mescia F, Lee JC, et al. Analysis of the b cell receptor repertoire in six immune-mediated diseases. Nature. 2019;574(7776):122\u20136. https:\/\/doi.org\/10.1038\/s41586-019-1595-3.","journal-title":"Nature"},{"issue":"5","key":"432_CR68","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1172\/JCI38010","volume":"119","author":"MP Cancro","year":"2009","unstructured":"Cancro MP, D\u2019Cruz DP, Khamashta MA. The role of b lymphocyte stimulator (blys) in systemic lupus erythematosus. J Clin Invest. 2009;119(5):1066\u201373. https:\/\/doi.org\/10.1172\/JCI38010.","journal-title":"J Clin Invest"},{"issue":"12","key":"432_CR69","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1056\/NEJMoa2001180","volume":"383","author":"R Furie","year":"2020","unstructured":"Furie R, Rovin BH, Houssiau F, Malvar A, Teng YKO, Contreras G, et al. Two-year, randomized, controlled trial of belimumab in lupus nephritis. N Engl J Med. 2020;383(12):1117\u201328. https:\/\/doi.org\/10.1056\/NEJMoa2001180.","journal-title":"N Engl J Med"},{"issue":"2","key":"432_CR70","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.kint.2021.08.027","volume":"101","author":"BH Rovin","year":"2022","unstructured":"Rovin BH, Furie R, Teng YKO, Contreras G, Malvar A, Yu X, et al. A secondary analysis of the belimumab international study in lupus nephritis trial examined effects of belimumab on kidney outcomes and preservation of kidney function in patients with lupus nephritis. Kidney Int. 2022;101(2):403\u201313. https:\/\/doi.org\/10.1016\/j.kint.2021.08.027.","journal-title":"Kidney Int"},{"key":"432_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.ard.2025.11.015","author":"N Agmon-Levin","year":"2025","unstructured":"Agmon-Levin N, Ignatenko S, Gordienko A, Cortes-Hernandez J, Narongroeknawin P, Romanowska-Prochnicka K, et al. B cell depletion and baff receptor blockade with ianalumab (vay736) for the treatment of moderate-to-severe systemic lupus erythematosus: A phase 2 randomised, double-blind, placebo-controlled trial with subsequent open-label treatment. Ann Rheum Dis. 2025. https:\/\/doi.org\/10.1016\/j.ard.2025.11.015.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"432_CR72","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1136\/annrheumdis-2021-220920","volume":"81","author":"RA Furie","year":"2022","unstructured":"Furie RA, Aroca G, Cascino MD, Garg JP, Rovin BH, Alvarez A, et al. B-cell depletion with obinutuzumab for the treatment of proliferative lupus nephritis: a randomised, double-blind, placebo-controlled trial. Ann Rheum Dis. 2022;81(1):100\u20137. https:\/\/doi.org\/10.1136\/annrheumdis-2021-220920.","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"432_CR73","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1056\/NEJMoa2308917","volume":"390","author":"F M\u00fcller","year":"2024","unstructured":"M\u00fcller F, Taubmann J, Bucci L, Wilhelm A, Bergmann C, V\u00f6lkl S, et al. Cd19 car t-cell therapy in autoimmune disease \u2014 a case series with follow-up. New Engl J Med. 2024;390(8):687\u2013700. https:\/\/doi.org\/10.1056\/NEJMoa2308917.","journal-title":"New Engl J Med"},{"issue":"1","key":"432_CR74","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ard.2025.06.2132","volume":"85","author":"P Garantziotis","year":"2026","unstructured":"Garantziotis P, Beretta L, Lindblom J, Moysidou GS, Nikolopoulos D, Grieshaber-Bouyer R, et al. Differential molecular signatures in response to CD19-CAR T cell therapy compared with conventional pharmacotherapy in systemic lupus erythematosus. Ann Rheum Dis. 2026;85(1):153\u201363. https:\/\/doi.org\/10.1016\/j.ard.2025.06.2132.","journal-title":"Ann Rheum Dis"},{"key":"432_CR75","doi-asserted-by":"publisher","unstructured":"Alexander T, Kr\u00f6nke J, Cheng Q, Keller U, Kr\u00f6nke G. Teclistamab-induced remission in refractory systemic lupus erythematosus. N Engl J Med. 2024;391(9):864-6. https:\/\/doi.org\/10.1056\/NEJMc2407150.","DOI":"10.1056\/NEJMc2407150"},{"issue":"10522","key":"432_CR76","doi-asserted-by":"publisher","first-page":"2968","DOI":"10.1016\/S0140-6736(25)01671-X","volume":"406","author":"J Gao","year":"2026","unstructured":"Gao J, Li M, Sun M, Yu Y, Kong R, Xu X, et al. Efficacy and safety of allogeneic CD19 CAR NK-cell therapy in systemic lupus erythematosus: a case series in China. Lancet. 2026;406(10522):2968\u201379. https:\/\/doi.org\/10.1016\/S0140-6736(25)01671-X.","journal-title":"Lancet"}],"container-title":["Inflammation and Regeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41232-026-00432-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41232-026-00432-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41232-026-00432-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T19:01:33Z","timestamp":1784574093000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s41232-026-00432-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,18]]},"references-count":76,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["432"],"URL":"https:\/\/doi.org\/10.1186\/s41232-026-00432-6","relation":{},"ISSN":["1880-8190"],"issn-type":[{"value":"1880-8190","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,18]]},"assertion":[{"value":"16 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Tomohisa Okamura or T.O. belongs to the Social Cooperation Program, Department of Functional Genomics and Immunological Diseases, supported by Chugai Pharmaceutical. Keishi Fujio or K.F. serves as an Associate Editor of this journal and was not involved in the review or decision process for this manuscript.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"30"}}